{"DataElement":{"publicId":"3180258","version":"1","preferredName":"Person Human Immunodeficiency Virus Highly Active Antiretroviral Therapy Clinical Trial Eligibility Criteria Ind-2","preferredDefinition":"the yes/no indicator whether a person is positive for Human Immunodeficiency Virus, a cytopathic retrovirus, and being treated with antiretroviral therapy, drug therapy which targets retrovirus function, as an element of a personal medical history which is necessary to allow an individual to participate in a specific clinical trial._the yes/no indicator related to the patient's eligibility to participate in the clinical trial.","longName":"3179417v1.0:2018257v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3179417","version":"1","preferredName":"Person Human Immunodeficiency Virus Highly Active Antiretroviral Therapy Clinical Trial Eligibility Criteria","preferredDefinition":"information related to a person being positive for Human Immunodeficiency Virus, a cytopathic retrovirus, and being treated with antiretroviral therapy, drug therapy which targets retrovirus function, as an element of a personal medical history which is necessary to allow an individual to participate in a specific clinical trial.","longName":"2236731v1.0:3179415v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3179415","version":"1","preferredName":"Human Immunodeficiency Virus Highly Active Antiretroviral Therapy Clinical Trial Eligibility Criteria","preferredDefinition":"Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.:Drug therapy which targets retrovirus function by multiple mechanisms.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C14219:C16165:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Immunodeficiency Virus","conceptCode":"C14219","definition":"The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Highly Active Antiretroviral Therapy","conceptCode":"C16165","definition":"Drug therapy which targets retrovirus function by multiple mechanisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9892AA8D-A783-8711-E040-BB89AD436ABE","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9892AA8D-A794-8711-E040-BB89AD436ABE","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104893","version":"1","longName":"GOG-0230D","context":"NRG"},{"publicId":"10000081","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"4104906","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"10000082","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"4104993","version":"1","longName":"RTOG-1112","context":"NRG"},{"publicId":"10000276","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104930","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"10000275","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104892","version":"1","longName":"GOG-0229O","context":"NRG"}]},{"publicId":"5999742","version":"1","longName":"CRF CDEs","context":"CITN","ClassificationSchemeItems":[{"publicId":"5999747","version":"1","longName":"Eligibility CDEs","context":"CITN"}]}],"AlternateNames":[{"name":"PtAntiViralTpyIND","type":"COG GDE Short Name","context":"COG"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"3179417v1.0:2018257v1.0","type":"USED_BY","context":"NRG"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"3179417v1.0:2018257v1.0","type":"USED_BY","context":"CITN"}],"ReferenceDocuments":[{"name":"Is the patient HIV positive o","type":"Preferred Question Text","description":"Is the patient HIV positive on combination antiretroviral therapy?","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Is the patient HIV positive and on combination antiretroviral therapy?","url":null,"context":"CTEP"},{"name":"CRF Text 2","type":"Alternate Question Text","description":"Is the patient known to be HIV positive with a baseline CD4 count of <250 cells/mm3 or have a history of AIDS indicator conditions","url":null,"context":"CTEP"},{"name":"NRG_CRF Text","type":"Alternate Question Text","description":"Is the patient HIV positive AND on combination antiretroviral therapy?","url":null,"context":"NRG"},{"name":"COG_CRF_TEXT_1","type":"Alternate Question Text","description":"Does the patient require antiretroviral therapy","url":null,"context":"COG"},{"name":"CITN","type":"Alternate Question Text","description":"maintained on stable antiretroviral therapy with no significant drug interactions","url":null,"context":"CITN"},{"name":"CITN Text","type":"Alternate Question Text","description":"Must be stable on their anti-retroviral regimen, and they must be healthy from an HIV prespective","url":null,"context":"CITN"},{"name":"CRF TEXT 3","type":"Alternate Question Text","description":"Is the patient HIV positive and under treatment with highly active antiretroviral therapy?","url":null,"context":"NRG"},{"name":"CITN-1","type":"Alternate Question Text","description":"Patient is stable on their anti-retroviral regimen, and is healthy from an HIV perspective.","url":null,"context":"CITN"},{"name":"CRF Text 4","type":"Alternate Question Text","description":"Is the patient on a stable highly active antiretroviral therapy (HAART) regimen with no drug-drug interaction with UGT1A9?","url":null,"context":"CTEP"},{"name":"CRF Text 5","type":"Alternate Question Text","description":"Within 4 weeks prior to randomization was the patient on a stable regimen of highly active anti-retroviral therapy HAART?","url":null,"context":"CTEP"},{"name":"CRF TEXT 6","type":"Alternate Question Text","description":"Does the patient have a known HIV positive status","url":null,"context":"NRG"},{"name":"CRF Text 7","type":"Alternate Question Text","description":"Is the patient on effective anti-retroviral therapy with undetectable viral load within 6 months?","url":null,"context":"CTEP"},{"name":"NRG_CRF_Text_2","type":"Alternate Question Text","description":"Is the patient HIV positive (on effective anti-retroviral therapy) with a detectable viral load within 6 months and have a CD4 count less than 200 cells/microliter within 60 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Is the patient on effective anti-retroviral therapy with undetectable viral load within 6 months?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text_3","type":"Alternate Question Text","description":"Is the patient HIV infected on effective anti retroviral therapy with an undetectable viral load within 6 months prior to registration?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text_4","type":"Alternate Question Text","description":"Is the patient  HIV infected (on effective anti-retroviral therapy) with detectable viral load within 6 months prior to registration","url":null,"context":"NRG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"If patient is an HIV-infected patient on an effective anti-retroviral therapy with an undetectable viral load within 6 months, is the patient receiving strong anti-retroviral inhibitors or inducers of CYP3A4, CYP2D6, and/or MRP2 transporter protein?","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F8D0CD-3643-DF81-E040-BB89AD433E5E","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-01-03","modifiedBy":"CLOHNES","dateModified":"2022-11-15","changeDescription":"Replaced VD Eligibility Ind-2 2018257v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}